Gimv Health & Care Fund managed by GIMV NV (ENXTBR:GIMB), Mérieux Développement SAS and the management of Stiplastics S.A.S. agreed to acquire 92.5% stake in Stiplastics S.A.S. from Stage Capital Management Limited on January 18, 2018. Stiplastics will remain under the operational management of Jérôme Empereur and Laetitia Le Gall. The transaction is expected to close by the end of January 2018. Philippe Croppi and Marie-Clémence Harang of Clearwater Corporate Finance acted as the financial advisors, Henri Pieyre de Mandiargues and Nicolas de Courtivron of McDermott Will & Emery and Stéphane Rodriguez of Lamartine Conseil acted as the legal advisors and Christophe Delas and Florian Rubi of Eight Advisory acted as the financial advisor and provided financial due diligence for GIMV and Mérieux. Ludovic Rodié, Philippe Rapin and Elliot Thiéblin of Lincoln International acted as the financial advisors, Thomas Hermetet of HPML acted as the legal advisor, Pascal Rhoumy of EY acted as the accountant and provided financial due diligence and Vincent Genet of Alcimed provided strategic due diligence for Stage Capital Management.